Neutrophils News and Research

RSS

Implantable mechanotherapeutic drug delivery platform helps overcome host immune response

Implantable devices that release insulin into the body hold promise as an alternative way to treat diabetes without insulin injections or cannula insertions. However, one obstacle that has prevented their use so far is that the immune system attacks them after implantation, forming a thick layer of scar tissue that blocks insulin release.

8 Aug 2022

What is the immunopathogenesis of pediatric COVID-19?

Researchers assessed the immunopathogenesis of COVID-19 infection in children.

1 Aug 2022

Study suggests a possible treatment approach for cancer and cardiovascular disease

A key molecule for cancer metastasis has been identified as a molecule already known for its involvement in cardiovascular disease, suggesting a possible treatment approach for both diseases simultaneously.

25 Jul 2022

Scientists explore COVID-19-associated pulmonary aspergillosis

Researchers computationally investigated the causes of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA).

25 Jul 2022

Researchers discover new key protection against COVID-19 in saliva

The novel coronavirus (SARS-CoV-2) has spread around the world at an unprecedented rate, evading containment countermeasures.

19 Jul 2022

Researchers use lasers to turn white blood cells into medicinal microrobots

Medicinal microrobots could help physicians better treat and prevent diseases. But most of these devices are made with synthetic materials that trigger immune responses in vivo.

13 Jul 2022

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

Immunotherapy has revolutionized treatment for many forms of cancer, but glioblastoma multiforme (GBM), the most common and deadly form of brain cancer, has remained untouched.

11 Jul 2022

The replicative ability and pathogenicity of Omicron BA.4 and BA.5 isolates in hamsters

Researchers characterized the clinical isolates of SARS-CoV-2 Omicron BA.4 and BA.5.

8 Jul 2022

Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

A new study investigated the role of complement component 5a (C5a) and its receptor (C5a receptor type 1, C5aR1) in the pathophysiology of COVID-19.

6 Jul 2022

Bisphosphonates appear to improve COVID-19 exposure outcomes

A new retrospective study examines the effect of bisphosphonates on COVID-19 outcomes.

27 Jun 2022

Study finds traditional African drug inhibits growth of SARS-CoV-2 infection

Researchers evaluated the efficacy of PHELA, a traditional African drug, against SARS-CoV-2 in vitro.

21 Jun 2022

Math model predicts several useful new drug combinations that may help treat heart attacks

Researchers used mice to develop a mathematical model of a myocardial infarction, popularly known as a heart attack.

17 Jun 2022

Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

15 Jun 2022

Study reveals the dynamics of disease recovery after severe COVID-19

Recovery from severe COVID-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system.

15 Jun 2022

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

Determining how SARS-CoV-2, the virus causing COVID-19, moves from an early stage of infection, when patients are largely asymptomatic, into a later stage when people may experience life-threatening inflammation in the lungs, is a critical step in understanding how to target and treat the disease more efficiently.

14 Jun 2022

Neutrophils News and Research

Implantable mechanotherapeutic drug delivery platform helps overcome host immune response

What is the immunopathogenesis of pediatric COVID-19?

Study suggests a possible treatment approach for cancer and cardiovascular disease

Scientists explore COVID-19-associated pulmonary aspergillosis

Researchers discover new key protection against COVID-19 in saliva

Researchers use lasers to turn white blood cells into medicinal microrobots

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

The replicative ability and pathogenicity of Omicron BA.4 and BA.5 isolates in hamsters

Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

Bisphosphonates appear to improve COVID-19 exposure outcomes

Study finds traditional African drug inhibits growth of SARS-CoV-2 infection

Math model predicts several useful new drug combinations that may help treat heart attacks

Fc-effector functions for selecting COVID-19 convalescent plasma

Study reveals the dynamics of disease recovery after severe COVID-19

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

MIT researchers design new sensor to distinguish between viral and bacterial pneumonia

Gastrointestinal complications caused by SARS-CoV-2

Brain motor and fear circuits orchestrate the immune response to acute stress

Inhibiting immune response-related enzyme holds promise in preventing or treating severe COVID-19

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®